---
schema: review-dialogue-handoff/v1
stage: provisional
working_title: "Explicit Drug–Protein Interaction Learning for DTI Prediction: Mechanisms, Interpretation, and Reliability"
dialogue_language: zh-CN
review_type: narrative-critical
literature_status: not-searched
---

# Review Dialogue Summary — Illustrative provisional example

> **EXAMPLE ONLY**: This is a hypothetical demonstration based on an illustrative review topic, not an actual user's completed dialogue. No literature search, source verification, or author confirmation has occurred.

**Executive handoff:** The example research objective is to examine explicit drug–protein interaction modeling in drug–target interaction prediction. The recommended critical angle is to distinguish architectural attention/fusion operators from evidence that a learned signal corresponds to physical binding contacts. User decisions have not been confirmed. The most important risk is a mixed-level taxonomy and a failure to distinguish attention visualization from contact validation. Before drafting a review, check actual related reviews and original methods papers.

## 1. Topic and original research goals

- `USER_GIVEN` (hypothetical illustrative input): “Review explicit drug–protein interaction modeling and interpretability in DTI; compare methodological paradigms.”
- `ASSISTANT_PROPOSED`: Narrow the central scientific problem from general predictive performance to the relationship between learned cross-modal associations and independently observed molecular interactions.
- This example has **not** recorded real input from the present user.

## 2. Scope, exclusions, review type and audience

- Provisional type: narrative-critical, because the research objective is a cross-method conceptual and evaluation-focused synthesis; this is a planning preference, not an executed review protocol.
- In-scope: explicit inter-molecular interaction modules; sequence/graph/structure representation context needed to understand these modules; evaluation and faithfulness of interpretation.
- Provisional exclusions: pure unimodal encoding without explicit pair coupling; broad DTI algorithms unrelated to the review's core question.
- Audience: method developers and structural/computational pharmacologists. Date range not decided; no literature search performed.

## 3. Central thesis and research questions

**Hypothesis (not a scientific conclusion):** An interaction map that is useful for DTI prediction does not automatically provide an empirically validated residue–atom contact explanation.

| ID | Question | Role | Decision status |
| --- | --- | --- | --- |
| RQ1 | Which model components explicitly couple drug and protein representations? | Clarify architecture | ASSISTANT_PROPOSED |
| RQ2 | Which training and evaluation signals permit a physical interaction interpretation? | Separate predictive association from mechanistic evidence | ASSISTANT_PROPOSED |
| RQ3 | Under what data/split settings are interaction maps reliable? | Define comparability | OPEN |

## 4. Concept map and proposed taxonomy

Use a two-layer distinction: **interaction operator** versus **supervision/validation**. Operator candidates to check in actual papers include pairwise scoring, co-attention, bilinear interactions, cross-modal graph updates, and geometry-aware operations. A contact-prediction auxiliary task should generally be recorded as **supervision/output**, not automatically as a same-level peer of co-attention.

- `ASSISTANT_PROPOSED` Taxonomy A: rows = explicit coupling operators; columns = whether physical contact geometry and/or contact labels are used during learning and validation.
- Overlap stress test: A model may combine cross-attention with contact supervision and graph geometry; a mutually exclusive flat list may force a false choice.
- Coverage gap: Need original methods papers to determine which purported operator families actually occur and what exceptions exist.

## 5. Competing frameworks and critical debate

| Option / claim | Strongest rationale | Counterargument | Proposed resolution | Status |
| --- | --- | --- | --- | --- |
| Operator-centric chapters | Easy to locate implementation differences | May mix architecture with claims about mechanisms | Operator-level matrix plus evidence-centric chapters | ASSISTANT_PROPOSED |
| Reliability-centric chapters | Connects interpretation to actual evidence | Risk of understating architectural innovations | Show operator comparison in tables | OPEN |
| “Attention identifies binding contacts” | Appealing visual narrative | Without a structural ground truth or perturbation, association may not imply physical contact | Seek contact-ground-truth and perturbation benchmarks | DISPUTED |

## 6. Comparative evaluation dimensions

| Dimension | Definition | Comparability requirement | Verification need |
| --- | --- | --- | --- |
| Interaction granularity | Atom–residue vs global interaction features | Define tokenization and mapping to atoms/residues | CHECK_METHOD |
| Biological target | Binding outcome vs affinity vs efficacy | Keep endpoint definitions distinct | CHECK_COMPARABILITY |
| Interpretable signal | Attention weight vs predicted contact | Need physical ground truth or intervention design | CHECK_RESULT |
| Generalization | Random vs cold-target split | Verify target overlap and assay setting | CHECK_COMPARABILITY |

Do not infer a cross-paper ranking from superficially similar AUROC scores.

## 7. Candidate scholarly contributions

| ID | Contribution hypothesis | Why it matters | Overlap risk | Evidence needed |
| --- | --- | --- | --- | --- |
| N1 | Orthogonal map of explicit interaction operators versus physical-grounding evidence | Prevents mixing architectural and evidential categories | Prior interpretability and DTI reviews may already present this distinction | CHECK_NOVELTY |
| N2 | Evidence hierarchy for interaction heatmap faithfulness | Links claims to falsifiable tests | May overlap explainable-AI reviews | CHECK_NOVELTY |
| N3 | Evaluation checklist for cold-target and physical-contact generalization | Exposes benchmarking pitfalls | Prior benchmarking protocols may cover much of it | CHECK_NOVELTY |

## 8. Proposed English review outline

1. **Scientific question and scope** — why predicting DTI is not identical to explaining molecular contacts; needs primary definitions.
2. **Representation and interaction ontologies** — distinguish inputs, operators, supervision, and outputs; needs original methods papers.
3. **Architectural paradigms** — contrast forms of explicit coupling and their assumptions; needs verified architecture table.
4. **From latent weights to physical evidence** — define contact interpretation criteria and appropriate validation.
5. **Evaluation, leakage, and generalization** — compare valid protocols, controls and endpoints, not cross-paper score tables.
6. **Open problems and falsifiable research agenda** — prioritize empirical tests to resolve disputed interpretations.
7. **Conclusions** — only support after searching and reading the literature.

## 9. Planned figures and tables

| ID | Type | Question answered | Required evidence | Status |
| --- | --- | --- | --- | --- |
| F1 | Orthogonal taxonomy matrix | What is an interaction operation versus physical supervision? | Verified original model methods | PROPOSED |
| F2 | Validation ladder | What evidence makes a contact explanation credible? | Examples of structural and perturbation checks | PROPOSED |
| T1 | Model comparison schema | Which differences are architectural versus task-related? | Verified papers, datasets, splits, labels | PROPOSED |

## 10. Candidate sources and evidence status

No source titles, DOI values, author names or experimental results are asserted in this example. Literature search: `not-searched`. Candidate bibliography must be populated after real discovery. This is deliberate and prevents fabricated references.

## 11. Claim-verification backlog and search seeds

| Priority | ID | Claim or question | Risk if false | Evidence required | Proposed search terms — NOT RUN |
| --- | --- | --- | --- | --- | --- |
| P0 | C01 | Does a similar operator-by-evidence taxonomy already exist? | Undermines proposed novelty | CHECK_NOVELTY | DTI interaction interpretability taxonomy review |
| P0 | C02 | How often do models compare learned interactions with actual residue–ligand contacts? | Core research argument changes | CHECK_METHOD, CHECK_RESULT | drug protein attention contact validation structural benchmark |
| P1 | C03 | Which benchmarks ensure cold-target generalization? | Limits practical conclusion | CHECK_COMPARABILITY | DTI cold target split interpretability evaluation |

No queries have been executed. Terms above are search seeds only.

## 12. Decision ledger and change history

| Decision ID | Issue | Current status | Provenance | Alternatives |
| --- | --- | --- | --- | --- |
| D01 | Review type | Narrative-critical proposed | ASSISTANT_PROPOSED | Systematic evidence mapping if author chooses |
| D02 | Main organizing dimension | Operator × physical evidence proposed | ASSISTANT_PROPOSED | One-dimensional operator taxonomy |
| D03 | How much structure modeling to include | Not decided | OPEN | Include as comparator versus only explicit maps |

Recorded reversals: none (this is a hypothetical example, with no genuine multi-turn user feedback). No `USER_CONFIRMED` decisions exist.

## 13. Open questions and prioritized next steps

- `OPEN`: Should faithfulness of physical interaction interpretation be the headline question, or a secondary criterion within a general DTI model-method review?
- `OPEN`: Should models requiring experimental protein–ligand complex structures be in the same table as sequence-only pair models?
- Architecture would need revision if real reviews already establish this distinction, if no comparable empirical validation exists, or if the review's scope is too broad.
- Next: clarify headline question; search existing reviews; sample original methods papers to check taxonomy; define evidence hierarchy; create a traceable record/evidence matrix.

## 14. Downstream handoff brief (English)

**Topic:** Explicit drug–protein interaction learning for DTI prediction, including interpretability and scientific reliability.

**Author's research objective:** Illustrative only; not obtained from an actual user. Investigate explicit inter-molecular interaction modeling and claims of physical meaning.

**Proposed review type and audience:** Narrative-critical; method developers and computational pharmacologists.

**Scope and exclusions:** Explicit cross-modal drug–protein modules in scope; pure unimodal models provisionally excluded.

**Provisional central argument:** Distinguish coupling operators from empirical evidence that their outputs represent true contacts; not yet verified by literature.

**Intellectual architecture:** Operator-by-evidence taxonomy, plus sections addressing architecture, interpretation, benchmarking and unresolved questions.

**Decisions verified with user:** None. The entire example is provisional and not a transcript of any completed dialogue.

**Assumptions and controversies:** Attention faithfulness, acceptable comparisons across representations and endpoints, novelty relative to previous surveys.

**Source status:** NOT SEARCHED; no paper-level source verification performed.

**First actions for evidence-first-review-writer:** Identify previous reviews; verify original methods and sources; inspect evaluation and ground-truth criteria; revise the taxonomy if the actual literature contradicts the dialogue framework. Do not paste this draft as factual English manuscript prose.
